An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cue Health to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Cue Health (NASDAQ: HLTH), a healthcare technology company, has announced its management team's participation in two upcoming conferences. The first is the 43rd Annual Goldman Sachs Global Healthcare Conference on June 15, 2022, at 6:20 p.m. Eastern Time, held at the Terranea Resort, Rancho Palos Verdes. The second event is the 7th Annual Cowen FutureHealth Conference on June 22, 2022, at 1:35 p.m. Eastern Time. For further details and access to the presentations, visit www.cuehealth.com.
Positive
None.
Negative
None.
SAN DIEGO--(BUSINESS WIRE)-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following conferences:
43rd Annual Goldman Sachs Global Healthcare Conference Presenting on Wednesday, June 15, 2022 at 6:20 p.m. Eastern Time at the Terranea Resort in Rancho Palos Verdes. The live audio webcast and replay of the presentation may be accessed for 90 days on the “Investor Relations” section of the company’s website at: www.cuehealth.com.
7th Annual Cowen FutureHealth Conference Presenting on Wednesday, June 22, 2022 at 1:35 p.m. Eastern Time
About Cue Health
Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India’s Central Drugs Standard Control Organization, and PSAR authorization from Singapore’s Health Sciences Authority. Cue Health was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
